CMS
60
-2
REGN
59
2
RIG
40
2
SE
49
2
PYPL
52
2
ZTS
21
2
ALLE
44
3
CA
30
3
TXN
50
2
SWKS
55
2
IRM
41
10
CTAS
40
-2
CHRW
82
3
EOG
33
-3
FTI
69
11
ADT
50
2
A
43
-5
DHR
66
2
NTAP
59
4
PWR
56
3
CMS
60
-2
REGN
59
2
RIG
40
2
SE
49
2
PYPL
52
2
ZTS
21
2
ALLE
44
3
CA
30
3
TXN
50
2
SWKS
55
2
IRM
41
10
CTAS
40
-2
CHRW
82
3
EOG
33
-3
FTI
69
11
ADT
50
2
A
43
-5
DHR
66
2
NTAP
59
4
PWR
56
3
Financhill
Back

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
75

IVOV
Vanguard S&P Mid-Cap 400 Value Index Fund ETF

Last Price:
$104.11
Seasonality Move:
4.79%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
75
Vanguard S&P Mid-Cap 400 Value Index Fund ETF (IVOV) is a Buy

Is Vanguard S&P Mid-Cap 400 Value Index Fund ETF a Buy, Sell or Hold?

  • The current Vanguard S&P Mid-Cap 400 Value Index Fund ETF [IVOV] share price is $104.16. The Score for IVOV is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
  • IVOV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

IVOV Stock Price Chart

What is Vanguard S&P Mid-Cap 400 Value Index Fund ETF's stock price today?

  • The Vanguard S&P Mid-Cap 400 Value Index Fund ETF share price today is $104.16
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IVOV is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

IVOV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.07 Buy
Relative Strength Index (14 RSI): 60.91 Buy
Chaikin Money Flow: 7215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.04 - 104.2) Buy
Bollinger Bands (100): (98 - 102.42) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

IVOV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.14 Buy
20-day SMA: 102.69 Buy
50-day SMA: 100.74 Buy
200-day SMA: 96.35 Buy
8-day EMA: 103.7 Buy
20-day EMA: 102.7 Buy
50-day EMA: 101.35 Buy
200-day EMA: 98.1 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Earnings Growth & IVOV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

Vanguard S&P Mid-Cap 400 Value Index Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):